Home infusion as a viable option has been flourishing as a result of overall trends in the healthcare market that favor the home setting for care. Due to evolutionary changes in patient care resulting from the COVID-19 pandemic, the anticipated future rise of home infusion is happening now. For pharmaceutical manufacturers who have an infusion asset in their pipeline or are considering acquiring one, the opportunities and challenges prompted by home infusion need to be factored into any effective go-to-market strategy.
Download our detailed white paper for a deep dive into the drivers and barriers to adoption, as well as tips for improving your go-to-market strategies.
[WEBINAR] Why digital analysis is critical for pharma marketers
Join us for a complimentary webinar as Ipsos VP of Healthcare Digital Strategy Steve Reeves will take you through a pragmatic, detailed process for understanding how to think about digital readiness and the utilization of social and other digital data sources for insights gathering in healthcare.